An experimental anti-cancer drug can prevent — and even reverse — potentially fatal cardiovascular damage in a mouse model of progeria, a rare genetic disorder that causes the most dramatic form of human premature aging researchers have reported.
An experimental anti-cancer drug can prevent — and even reverse — potentially fatal cardiovascular damage in a mouse model of progeria, a rare genetic disorder that causes the most dramatic form of human premature aging researchers have reported.